Published September 30, 2021 | Version v1
Journal article Open

An Inertial Sensor-Based Gait Analysis Pipeline for the Assessment of Real-World Stair Ambulation Parameters

  • 1. Machine Learning and Data Analytics Lab (MaD Lab), Department of Artificial Intelligence in Biomedical Engineering (AIBE), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), D-91052 Erlangen, Germany
  • 2. Department of Molecular Neurology – Movement Analysis, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
  • 3. Department of Computer Science, Friedrich-Alexander University Erlangen-Nuernberg, Immerwahrstr. 2a, 91058 Erlangen, Germany
  • 4. FAU Erlangen Department of Computer Science, Carl-Thiersch-Straße 2b, 91052 Erlangen, Germany

Description

Climbing stairs is a fundamental part of daily life, adding additional demands on the postural control system compared to level walking. Although real-world gait analysis studies likely contain stair ambulation sequences, algorithms dedicated to the analysis of such activities are still missing. Therefore, we propose a new gait analysis pipeline for foot-worn inertial sensors, which can segment, parametrize, and classify strides from continuous gait sequences that include level walking, stair ascending, and stair descending. For segmentation, an existing approach based on the hidden Markov model and a feature-based gait event detection were extended, reaching an average segmentation F1 score of 98.5% and gait event timing errors below ±10ms for all conditions. Stride types were classified with an accuracy of 98.2% using spatial features derived from a Kalman filter-based trajectory reconstruction. The evaluation was performed on a dataset of 20 healthy participants walking on three different staircases at different speeds. The entire pipeline was additionally validated end-to-end on an independent dataset of 13 Parkinson’s disease patients. The presented work aims to extend real-world gait analysis by including stair ambulation parameters in order to gain new insights into mobility impairments that can be linked to clinically relevant conditions such as a patient’s fall risk and disease state or progression.

This work was supported by the Mobilise-D project that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 820820. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Content in this publication reflects the authors’ view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

Files

sensors-21-06559-v2.pdf

Files (10.8 MB)

Name Size Download all
md5:c7f5339115d325c4e7b7927d4bf2529c
10.8 MB Preview Download

Additional details

Identifiers

Funding

MOBILISE-D – Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement 820820
European Commission